Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and Neoplasm Metastasis

4-butyrolactone has been researched along with Neoplasm Metastasis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anant, S; Hegde, MV; Kadam, SS; Mali, AV; Padhye, SB1
Chen, X; De, S; Rotenberg, SA; Tsimounis, A1
Hu, XJ; Li, Y; Liu, CM; Xiong, XY1
Chen, J; Thompson, LU1
Miura, D; Miura, Y; Saarinen, NM; Santti, R; Yagasaki, K1

Reviews

1 review(s) available for 4-butyrolactone and Neoplasm Metastasis

ArticleYear
Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.
    European journal of pharmacology, 2019, Jun-05, Volume: 852

    Topics: 4-Butyrolactone; Animals; Humans; Lignans; Neoplasm Metastasis; Neoplasms

2019

Other Studies

4 other study(ies) available for 4-butyrolactone and Neoplasm Metastasis

ArticleYear
Phosphorylation of α-tubulin by protein kinase C stimulates microtubule dynamics in human breast cells.
    Cytoskeleton (Hoboken, N.J.), 2014, Volume: 71, Issue:4

    Topics: 4-Butyrolactone; Breast; Cell Line, Transformed; Cell Movement; Cell Survival; Enzyme Activation; Female; Fluorescent Antibody Technique; Green Fluorescent Proteins; Humans; Microtubule-Associated Proteins; Microtubules; Models, Biological; Mutant Proteins; Neoplasm Metastasis; Phosphorylation; Phosphoserine; Protein Kinase C; rac1 GTP-Binding Protein; Recombinant Fusion Proteins; Triple Negative Breast Neoplasms; Tubulin; Valerates

2014
Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer.
    Nutrition and cancer, 2015, Volume: 67, Issue:8

    Topics: 4-Butyrolactone; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Cytoskeleton; Focal Adhesion Kinase 1; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression; Humans; Ki-67 Antigen; Lignans; Neoplasm Invasiveness; Neoplasm Metastasis; Paxillin; Proliferating Cell Nuclear Antigen; RNA, Messenger; S Phase; Signal Transduction

2015
Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro.
    Breast cancer research and treatment, 2003, Volume: 80, Issue:2

    Topics: 4-Butyrolactone; Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Humans; Lignans; Neoplasm Invasiveness; Neoplasm Metastasis; Phytotherapy; Receptors, Estrogen; Tamoxifen

2003
Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats.
    Nutrition and cancer, 2007, Volume: 58, Issue:1

    Topics: 4-Butyrolactone; Animals; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lignans; Liver Neoplasms, Experimental; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Rats; Tumor Cells, Cultured

2007